bluebird (BLUE) Underperforms Industry YTD Amid Challenges
Yahoo Finance · 7 days ago
Open | 1.0100 |
High | 1.0300 |
Low | 0.9350 |
Mkt Cap | 183.8M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.0200 |
52 Wk. Low | 0.8800 |
52 Wk. High | 5.5300 |
Related stocks
Company in Cambridge, United States
bluebird bio, Inc., based in Somerville, Massachusetts, is a biotechnology company that develops gene therapies for severe genetic disorders. Wikipedia
(USD) | Q3 2023 | Y/Y |
---|---|---|
Revenue | 12.39M | 17,353.50% ▲ |
Net Income | -71.73M | - |
Diluted EPS | -0.66 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q4 2023 | -$0.64 | - |
Q3 2023 | -$0.67 | -$0.66 |
Q2 2023 | -$0.72 | -$0.67 |
S&P FuturesES=F | 5,058.50+11.00 (+0.22%) |
Dow FuturesYM=F | 38,516.00+48.00 (+0.12%) |
Nasdaq FuturesNQ=F | 17,393.50+43.50 (+0.25%) |
43.21+1.98% | |
272.24-1.30% | |
145.36+1.81% |